Importance of white cell, platelet cell ratio in long standing obstructive lung disease

Not Applicable

• Conditions: Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

• Registration Number: CTRI/2024/03/063588
• Lead Sponsor: Dr Satya Roy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

CASES-

1) Patients with diagnosis of acute exacerbation of COPD defined as acute worsening of respiratory symptoms such as breathlessness, cough with sputum severe enough requiring hospital admission

CONTROLS-

1) Clinically stable COPD patients diagnosed on the basis of GOLD guidelines admitted for other reasons in the medical ward or from the medicine and pulmonary medicine outpatient clinic will be taken as controls

Exclusion Criteria

1)Patients with bronchial asthma

2)Patients with bronchiectasis

3)Pulmonary tuberculosis patients

4)Patients on oral steroid treatment

5) Patients with other infective conditions- UTI, sepsis due to other causes etc

6)Patients with other inflammatory conditions-inflammatory arthritis, inflammatory bowel disease

7)Patients with autoimmune conditions- SLE etc

8)Patients with hematological disorders

9)Patients with malignancies

10)Patients with a recent MI/stroke

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To correlate NLR PLR, Procalcitonin, CRP, clinical outcomeTimepoint: at the time of recruitment

Secondary Outcome Measures

Name	Time	Method
nilTimepoint: nil